Objective To determine lengths and causes of pre-and in-hospital delays in thrombolytic treatment.
Introduction
Appropriate action should be taken to minimize the delay in the initiation of thrombolytic therapy in acute myocardial infarction. The delay can be divided into three components: the time required for the patient to recognize the critical nature of the symptoms and to seek medical care, the delay between the call for assistance and the arrival of the patient in hospital, and the time elapsing from hospital admission to initiation of thrombolytic therapy.
To reduce the delay before initiation of thrombolytic treatment, it is important to assess the different components of the delay and their duration in a normal clinical setting. Some of the large-scale controlled thrombolytic drug trials have also evaluated treatment delay [1, 2] . However, patients entering these mega-trials represent a sample of the acute myocardial infarction population selected by study inclusion and exclusion criteria. There are also several community-or hospitalbased treatment delay studies with relatively small sample sizes [3] [4] [5] but no large, nationwide studies analysing the different components of the total delay.
The Finnish Heart Association and Finnish Cardiac Society planned a programme to shorten delays from the start of acute myocardial infarction symptoms to the initiation of thrombolysis. The present national survey, which included university, central and general hospitals, was undertaken to provide background data for the programme.
Patients and methods
Finland has a population of 5·0 million. Annually approximately 18 000 patients are treated in Finnish hospitals and health centres with a diagnosis of confirmed or probable acute myocardial infarction. Patients are given thrombolysis, if indicated, in five university, 20 central and 26 general hospitals with catchment areas serving between 25 000 and 300 000 people. In rural areas many health centres staffed by general practitioners provide thrombolytic treatment.
In Finland, the telephone number for the emergency medical service is 112 throughout the country. The call is answered by trained personnel. The urgency of help is assessed and appropriate units dispatched. In rural areas, most patients with chest pain suggestive of acute myocardial infarction are usually first brought to the emergency room of the local health centre. In towns and cities which have university, general or regional hospitals, patients are taken directly to the hospital.
During the 3-month period in 1995, all patients receiving thrombolytic therapy for acute myocardial infarction were studied in 48 of the 51 Finnish university, central or general hospitals which administer thrombolytic therapy. These hospitals are responsible for providing medical care to 96·2% of the population. The remaining three general hospitals could not take part in the study. In addition to patients who received the thrombolytic therapy in hospital, we also included those who received treatment outside hospital (at a health centre, in an emergency medical system) and who were thereafter admitted to hospital participating in the present study. No data were gathered of acute myocardial infarction patients who were not given thrombolytic therapy.
Case record forms were completed by the emergency physician at the time of admission. The onset time of acute myocardial infarction symptoms was recorded as accurately as possible. The time the emergency medical service was called was obtained from forms completed by the emergency medical technicians. The starting time of the drive to hospital was sought from patients who had arranged their own transport to hospital. The admission time to hospital (or health centre if thrombolysis was given there) was recorded when the patient arrived. The pre-hospital transportation distance was also recorded. The precise time of initiation of the thrombolytic agent was obtained from the hospital records. Reasons for prolonged in-hospital delay (hypertension, busy in the emergency department) were recorded.
The age and sex of the patient and the possible history of a previous myocardial infarction or coronary artery disease were recorded. The electrocardiograms, on which the decision to give thrombolytic therapy was based, were analysed retrospectively by two independent cardiologists. ST-segment elevation d0·1 mV in two or more limb leads or d0·2 mV in two or more contiguous precordial leads or bundle branch block were regarded as electrocardiographic indications for thrombolysis (Finnish National Consensus meeting 1992) [6] . The factors influencing hospital-related delay (diagnostic problem, consultation of a senior colleague etc.) were recorded.
The time of onset of initial symptoms was available in all patients and the time of calling for assistance in 98·9%. The hospital admission time (or health centre admission time if thrombolysis was given there) was known in 98·5%, and the time of initiation of thrombolytic treatment was available for all patients. The information whether the patient called the emergency medical service or not, was available in 96·3%. In 94% of the patients, the electrocardiograms which formed the basis for the initiation of thrombolysis were available.
Statistical methods
Treatment delay data had a skewed distribution; therefore all data are presented as medians and 5 and 95 percentiles. The significance of differences in median times was determined using a Mann-Whitney U-test. Two-tailed P-values <0·05 were considered statistically significant. Variables influencing in-hospital delay were assessed with linear regression analysis and backward selection was used to identify the relevant variables. All analyses were performed with the SPSS for Windows version 6.1.
Results
During the 3 month study period, 2547 patients were admitted to the 48 hospitals because of acute myocardial infarction. One thousand and twenty of these patients were treated with thrombolytic therapy, but in eight of them a final diagnosis was other than acute myocardial infarction (unstable angina pectoris in five, pulmonary embolism in two, acute myocarditis in one). Thus, 1012 acute myocardial infarction patients treated with thrombolysis constitute the final study population. One-hundred and fifty-three (18%) patients were given thrombolysis in five university hospitals, 403 (46%) in 20 central hospitals and 314 (36%) in 23 general hospitals. A further 142 (14%) patients received treatment outside the hospital (10% in the health centre, 3% in the ambulance and 1% in a helicopter medical service). The characteristics of the study patients are presented in Fig. 1 and Table 1 . The mean age of the patients was 65·8 12·1 (standard deviation) years, with 23% of them being older than 75 years.
Delay between the onset of symptoms and calling for help (patient delay)
The median time from the onset of symptoms to calling for help was 60 min (5-491) (Fig. 2) . Remarkably, 21% of the patients waited for more than 3 h before seeking medical help. Patients with a history of previous myocardial infarction presented no shorter median delay than those without such a history (60 min and 64 min, respectively, ns). Males sought medical help 20 min earlier than females (60 min and 80 min, respectively, P=0·009). The age of the patient did not influence delay. An analysis by time of day revealed that patient delay was longest during the night between 2200h and 0400h (95 min), and shortest during the day between 0800h and 1800h (40 min) (Fig. 3 ). Patients with a large acute myocardial infarction judged by the sum of ST segment elevations >2·0 mV on the electrocardiogram had a trend towards a shorter patient delay than those with minor ST segment elevations (39 and 66 min, respectively, P-value 0·099).
Delay between calling for help and admission to medical facility (transport delay)
Only 52% of the patients called directly to the dispatch centre for help, whereas 48% contacted a relative, friend, family physician or did something else. Altogether, 58% of the patients were admitted directly to hospital, whereas 42% visited the emergency room of a health centre first. Median delay from the call for help to arrival in hospital was 40 min (10-170), which correlated with the transportation distance (in kilometres). If the patient was first examined in a health centre but did not receive thrombolysis there, the median transport delay was considerably longer than in patients admitted directly to a hospital, even when the distance was identical (79 min and 30 min, respectively, P=0·001) (Fig. 4) . Transport delay was shortest (20 min) when thrombolytic therapy was given in a health centre before transportation to hospital.
Pre-hospital delay
The median time from the onset of symptoms of acute myocardial infarction to admission to hospital was 130 min (30-585). Only 21% of the patients were admitted to the hospital within 1 h and in 13% the delay was over 6 h.
In-hospital delay
The median in-hospital delay for thrombolysis was 40 min . We observed no significant difference in delay between university, central and general hospitals (32, 43 and 40 min, respectively). In individual hospitals, the median delay ranged from 14 min to 
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125 min (Fig. 5) . In eight of the 48 hospitals (17%) the median delay was within 30 min and in six (13%) more than 1 h. In 33% of in-hospital thrombolysis treatments, the emergency physician had either difficulty in diagnosing acute myocardial infarction or in deciding whether or not to give thrombolysis. Diagnostic difficulties were associated with minor electrocardiographic changes as compared to other patients (Fig. 6) . The median sum of ST segment elevations was 0·7 mV in patients with anterior acute myocardial infarction and diagnostic difficulties, 1·0 mV in those without any diagnostic difficulties and in patients with inferior acute myocardial infarction 0·3 mV and 0·5 mV, respectively (P-value <0·001). However, the study design does not allow us to verify the exact character of diagnostic difficulties. 
Figure 4
Median transport delay in patients who were examined in a health centre which did not initiate thrombolysis as compared to those admitted directly to hospital over the same distance.
Other reasons for the prolonged in-hospital delay (hypertension, busy hours in emergency department etc.) were reported in 4%. The delay was doubled if there were diagnostic difficulties or there was a need to consult a senior colleague before the initiation of the thrombolysis (61 min vs 30 min, respectively P=0·001). On the other hand, the time of day had no impact on the in-hospital delay. When thrombolytic therapy was given in a health centre, the median delay from health centre admission to treatment was 30 min. In hospitals where thrombolysis was routinely given in the emergency department, the delay was 10 min shorter than in those hospitals where thrombolysis was given in the coronary care unit or inpatient ward (35 min and 45 min, respectively, P=0·001).
Variables influencing the in-hospital delay were assessed with linear regression analysis. Variables included into the model were gender, age, a history of previous myocardial infarction, the location of acute myocardial infarction, the sum of ST-segment elevations, the presence of bundle branch block, the presence of diagnostic difficulties in identifying the indications for thrombolysis and the place where thrombolysis is given. In the linear regression analysis, the only significant factor influencing in-hospital delay was the presence of diagnostic difficulties in identifying indications for thrombolysis (B=59·230, SE(B)=8·116, P-value <0·0001), but this factor explained only 12% of the observed variation.
Total delay
The median interval between the onset of symptoms and the initiation of the thrombolytic therapy was 160 min (30-647). Only 13% of the patients received thrombolysis within 60 min and 25% between 61 and 120 min after the onset of symptoms (Fig. 2) . The total treatment delay was more than 6 h in 16% of the patients.
The total treatment delay was considerably shorter when thrombolytic therapy was provided outside the hospital (83 min in an ambulance or helicopter and 125 min in a health centre P-value=0·001) compared with thrombolysis received in hospital (165 min). No 
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significant difference in total delay between the various types of hospitals was observed.
Accuracy of initial electrocardiographic indication to thrombolytic therapy
ST elevations fulfilling the criteria for thrombolytic therapy were observed in 829 (83%) of the patients and bundle branch block in 20 (2%). The remaining 15% of electrocardiograms did not fulfil the present criteria for thrombolysis. Four percent of the patients had fewer ST-segment elevations than demanded by the criteria. Ischaemic ST-segment depression and/or T-wave changes were found in 8%. The remaining 3% had no marked electrocardiographic abnormalities.
Discussion
The interval between the onset of an acute myocardial infarction and the initiation of infarct-limiting therapy is a crucial factor for prognosis, since even a relatively short curtailing of the delay in reperfusion has a major impact on survival [7, 8] . Although direct angioplasty may be superior in restoration of patency and in decreasing mortality [9] [10] [11] , thrombolytic drug treatment will remain the cornerstone of reperfusion therapy in general practice.
The current study represents the Finnish population treated for acute myocardial infarction with thrombolysis extremely well. The pre-hospital delay in this non-selected material covering all patients treated with thrombolysis was slightly longer than in previous reports, with more or less selected patient populations, and accounted for the major part of the thrombolysis delay ( Table 2 ). The delay in seeking help varied greatly. The majority of the patients obtained access to medical care too late to gain maximum benefit from the thrombolytic therapy. Women, and patients whose symptoms started during the night or early morning had the longest delay times. Also, only a half of the patients made their initial contact with the emergency medical service. Consistent with previous studies [20, 21] our patients with a previous history of myocardial infarction or coronary artery disease did not seek help more rapidly than those without such a history. This is alarming, since the patients with diagnosed coronary artery disease should have already received adequate information about the urgency of seeking prompt treatment in symptoms suggestive of acute myocardial infarction.
Our findings emphasize the importance of prompt action when people are confronted with an acute heart attack. The patient-related delay, constituting more than 60% of the total delay, is the longest, but it is very difficult to alter people's behaviour [14, 22, 23] . Reorganizing the emergency medical service and emergency department routines is also necessary to shorten thrombolysis delays. Our results influenced the target of the national campaign begun in October 1996, organized by the Finnish Heart Association and the Finnish Cardiac Society. In addition to concentrating on the influence in the public, the steering committee decided to develop education material for dispatch centre personnel and for emergency physicians. Delay times of chest pain patients were recorded before the campaign and they were recorded after the campaign in a different survey.
The length of the transport delay depends on several local factors such as traffic problems, demographic features and distances. In sparsely populated Finland, the nearest hospital may be a long way away; in some cases the drive may take hours. The results of our study show that transport delays can be markedly shortened if thrombolytic therapy is initiated outside hospital; in Finland this means mainly in health centres.
In our study, the in-hospital treatment delay was shorter than in many earlier reports [3, 14, 21] although patients received thrombolysis within 30 min in only 17% of hospitals, which could be a realistic target of the door-to-needle delay time. The type of hospital did not influence the length of in-hospital delay, but there were great differences in the length of delay between individual hospitals. One reason for this, however, is that in some of the hospitals only a few patients were treated (e.g. in 18 hospitals less than 10 patients were treated during the study period) and the median delay may not be representative. The hospitals whose door-to-needle delay was shortest had trained ambulance crews and a pre-hospital 12-lead ECG was often taken in a patient with acute chest pain. Where there was a suspicion of an indication for thrombolysis, the crew informed the hospital by telephone.
An important result of our study is the finding that in one third of treatment decisions the physicians encountered diagnostic difficulties or needed to consult a senior colleague before treatment decision. In these cases, the in-hospital delay was remarkably longer than in patients without any diagnostic difficulties. The study design does not allow us to verify the exact character of these difficulties, but the most probable factors might Rogers et al. [3] 95 57 165 Birkhead et al. [4] 103 31*/85 † na Gonzalez et al. [12] na 50 155 Pell et al. [13] na 49 150 Herlitz et al. [14] 98 50 200 Trent et al. [15] na 20 155 Moore et al. [16] 95 25 142 Porter et al. [17] 150 40 na Newby et al. [18] 92 64 168 Rustige et al. [19] na 30 160 *Thrombolysis given in the Accident and Emergency department. †Patient transferred to the Cardiac Care Unit for thrombolysis.
have been minimal electrocardiographic abnormalities or suspected contraindications to thrombolysis. On the other hand, thrombolysis was given without ST-segment elevation or bundle branch block in 15% of cases. We cannot fully explain the reasons for this relatively high percentage. However, for the 4% of patients with minor ST-segment elevations the most obvious reason for thrombolytic treatment is the clinical signs of suspected acute myocardial infarction. In some earlier thrombolysis mega-trials, ST-segment depression or T-wave changes were among inclusion criteria for randomization. Although thrombolysis has not been beneficial for the patients with these electrocardiographic changes, these earlier inclusion criteria may have confused the physicians in general practice.
In the present survey, 40% of all the patients with confirmed acute myocardial infarction received thrombolytic therapy. This is in agreement with other recently published reports [3, [24] [25] [26] . It was not possible to obtain information from all patients with acute myocardial infarction, therefore, we do not know which proportion of acute myocardial infarction patients were left without thrombolysis although they had indication for this treatment. Generally, the proportion of patients treated with thrombolytic therapy is increasing, but it is still substantially less than the estimated 50-60% of patients with acute myocardial infarction who would potentially benefit from thrombolysis [24, 25] .
Conclusions
In our prospective national survey, which included almost all of the hospitals which use thrombolytic therapy for acute myocardial infarction, the delay in seeking help accounted for most of the total treatment delay and most patients arrived too late to obtain optimal benefit from thrombolysis. The length of the transport-related delay depends on traffic problems and demographic features and can be shortened if thrombolysis is initiated outside hospital when appropriate. In-hospital treatment delay is also remarkably prolonged in many hospitals and could be drastically reduced by better organization of hospital services i.e. by training the emergency room team and physicians and by using treatment protocols. A predetermined plan of action and an agreed checklist of eligibility criteria for thrombolytic therapy could make realistic a target of thrombolysis within 30 min of arrival in hospital, when the patient has symptoms typical of myocardial infarction. One important outcome of the present study is that in a nationwide Finnish educational campaign aimed at reducing patient delay there will be a specific education programme for dispatch centre, emergency medical service personnel and doctors working on emergency departments to help them streamline their procedures for handling patients with acute chest pain.
This work was supported by grants from the Finnish Heart Association.
